PM
IRWD icon

Parametrica Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Parametrica Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,214
Closed -$192K – 246
2022
Q1 		$192K Buy
+15,214
New +$174K 0.14% 206
2017
Q2 		– Sell
-18,059
Closed -$258K – 315
2017
Q1 		$258K Buy
+18,059
New +$247K 0.27% 189
2016
Q3 		– Sell
-13,712
Closed -$150K – 186
2016
Q2 		$150K Buy
+13,712
New +$134K 0.22% 191
2013
Q3 		– Sell
-13,113
Closed -$109K – 47
2013
Q2 		$109K Buy
+13,113
New +$159K 2.71% 15

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Parametrica Management's IRWD Position: Q2 2022 in Review

Parametrica Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 15,214 shares — an estimated $192K sold.

Parametrica Management first reported a position in IRWD in Q2 2013 and held it in 4 quarters. The position peaked at $258K in Q1 2017. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Parametrica Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Parametrica Management sold 15,214 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $192K.
  • Parametrica Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Parametrica Management's Ironwood Pharmaceuticals position peaked at $258K in Q1 2017.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Parametrica Management's 13F filing for Q2 2022, filed 22 Jul 2022.